Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12607000604404
ACTRN12607000604404
Recruiting
Phase 2

A prospective study investigating the impact of the addition of FDG-PET/CT on treatment decisions compared to standard pre-operative work up for patients with suspected pancreatic, peri-ampullary or bile duct malignancies

Royal Brisbane Hospital0 sites90 target enrollmentNovember 23, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Brisbane Hospital
Enrollment
90
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 23, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal Brisbane Hospital

Eligibility Criteria

Inclusion Criteria

  • •Suspected or proven localized pancreatic, ampullary or bile duct malignancy on the basis of standard investigations;
  • •\= 18 years old;
  • •Deemed suitable, based on tumour stage and medical fitness, to potentially undergo surgery or radiotherapy with curative intent;
  • •Available for follow up for at least 12 months from the date of PET/CT scanning;
  • •Able to provide Informed Consent.

Exclusion Criteria

  • •Claustrophobia;
  • •Uncontrolled diabetes mellitus;
  • •Pregnancy;
  • •Unable to provide informed consent;
  • •Inability to undergo PET/CT study;
  • •Any disease, condition, physical examination finding or clinical laboratory finding which, in the opinion of the investigator, makes the patient inappropriate for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A prospective study to evaluate the effect of the Molecular Adsorbent Recirculating System (MARS®) for patients with acute liver failureAcute liver failureAcute on chronic liver failure due to hepatitis BInjury, Occupational Diseases, Poisoning
ISRCTN40657638Gambro Korea Ltd (Korea, South)50
Recruiting
Not Applicable
se of serial 18F-fluorodeoxyglucose (FDG) and 18F-fluorothymidine (FLT) positron emission tomography (PET) & computed tomography (CT) for candidates with non-small cell lung cancer (NSCLC)receiving radical chemo-radiation therapylung cancerCancer - Lung - Non small cell
ACTRN12611001283965Peter MacCallum Cancer Centre60
Not yet recruiting
Not Applicable
Sonodissection for PG trainee
CTRI/2024/04/065572TMMC and LTMGH Sion Mumbai
Active, not recruiting
Not Applicable
A prospective study to assess the impact and benefits of an artificial intelligence system in double reading for breast cancer screening
ISRCTN95571932Kheiron Medical Technologies (United Kingdom)6,876
Recruiting
Not Applicable
A prospective observational study on the effects and mechanisms of zinc deficiency in patients with ulcerative colitislcerative colitis
JPRN-UMIN000036787Asahikawa Medical University30